$EW

Edwards Lifesciences Corporation

$86.28
+1.17 (+1.37%) Today

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

CEO
Mr. Bernard J. Zovighian
Employees
16,000
Headquarters
Irvine, CA
Sector
Healthcare
Industry
Medical Devices
Website
edwards.com

Key stats

Market Cap
$49.68B
P/E Ratio
46.64
Avg Volume (3M)
5.02M
EPS
$1.85
Day's Range
$84.61 – $86.31

Fundamentals as of Jun 16, 2026